Financial News
Articles published by Athersys, Inc.
From Athersys, Inc.
Via Business Wire
Athersys Licenses its Animal Health Assets to Ardent Animal Health
October 03, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Director Jane Wasman Appointed Board Chair
October 02, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Grant Awarded to Newcastle University to Research Athersys’ MultiStem® in Machine Perfusion Prior to Kidney Transplantation
September 06, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys, Inc. Announces Pricing of $3.5 Million Public Offering
August 17, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Appoints Neema Mayhugh, PhD to its Board of Directors
August 11, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Restructures Debt with Supplier
May 23, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys to Participate in The American Society for Neural Therapy and Repair Annual Conference
April 21, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys, Inc. Announces Closing of $3.7 Million Registered Direct Offering and Concurrent Private Placement
April 19, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys, Inc. Announces $3.7 Million Registered Direct Offering and Concurrent Private Placement
April 18, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 31, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Announces Successful Type B Meeting with the FDA
March 22, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion
February 14, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys to Host Business Update Conference Call on February 14th
February 02, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys to Participate in International Stroke Conference and BioProcess International
January 30, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in January
January 11, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Provides MultiStem Clinical Update
January 09, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Appoints Joseph Nolan to Its Board of Directors
January 05, 2023
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update
November 15, 2022
From Athersys, Inc.
Via Business Wire
Tickers
ATHX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.